Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 400,200 shares, a decrease of 36.9% from the January 15th total of 634,100 shares. Based on an average daily volume of 615,800 shares, the days-to-cover ratio is currently 0.6 days. Approximately 9.1% of the company’s stock are short sold.

Ainos Price Performance

Shares of NASDAQ AIMD opened at $0.74 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.33 and a current ratio of 1.37. Ainos has a 1-year low of $0.40 and a 1-year high of $3.10. The business has a fifty day moving average price of $0.59 and a 200 day moving average price of $0.55.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.